Ron Dagan

26PUBLICATIONS
37CO-AUTHORS
Infant and child healthPacific Peoples early childhood educationInnate immunityNeonatologyMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Dec 05, 2025
Differential Impact of Pneumococcal Conjugate Vaccines on Hospitalized Versus Outpatient Community-Acquired Alveolar Pneumonia in Children Younger Than 5 Years Suggests Differences in Pathogenesis.

Bart A van der Beek, David Greenberg, Guy Hazan

|Mar 07, 2025
Decline in Community-Acquired Alveolar Pneumonia Positive for Respiratory Syncytial Virus in Hospitalized Children Following Implementation of Pneumococcal Conjugate Vaccine (PCV) in Israel.

Ron Dagan, Bart Adriaan van der Beek, Tal Grupel

|Mar 04, 2025
Estimating the Serotype-Specific Association Between the Concentration of Vaccine-Induced Serum Antibodies and Protection Against Pneumococcal Colonization.

Anabelle Wong, Joshua L Warren, Laura Fitch

|Dec 17, 2024
Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine Is Reduced in Infants Immunized During the Respiratory Viral Season.

Ron Dagan, Bart A van der Beek

|Dec 10, 2024
Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo: Analysis From a Phase 3 Randomized Clinical Trial (MELODY).

Doug Arbetter, Vancheswaran Gopalakrishnan, Anastasia A Aksyuk

|Jan 14, 2024
Infants Receiving a Single Dose of Nirsevimab to Prevent RSV Do Not Have Evidence of Enhanced Disease in Their Second RSV Season.

Ron Dagan, Laura L Hammitt, Beatriz Seoane Nuñez

Pageof 5

Frequent Collaborators

4 joint publications

Shabir A Madhi

3 joint publications

Elizabeth J Kelly

2 joint publications

Anastasia A Aksyuk

2 joint publications

Ann Marie Stanley